Stock GKOS GLAUKOS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Glaukos Corporation

Equities

GKOS

US3773221029

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-10 pm EDT 		5-day change 1st Jan Change
110.5 USD +2.64% Intraday chart for Glaukos Corporation +3.71% +38.96%
May. 06 Jefferies Upgrades Glaukos to Buy From Hold, Raises Price Target to $125 From $84 MT
May. 02 Needham Adjusts Price Target on Glaukos to $113 From $108, Maintains Buy Rating MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jefferies Upgrades Glaukos to Buy From Hold, Raises Price Target to $125 From $84
MT
Needham Adjusts Price Target on Glaukos to $113 From $108, Maintains Buy Rating
MT
JPMorgan Adjusts Price Target on Glaukos to $110 From $108, Maintains Overweight Rating
MT
Glaukos : Q1 2024 Earnings Transcript
PU
Truist Raises Glaukos' PT to $125 From $120 After 'Solid' Q1 Beat, Keeps Buy Rating
MT
Glaukos : Q1 2024 GAAP to Non-GAAP Recs
PU
Glaukos : Q1 2024 Quarterly Summary
PU
Earnings Flash (GKOS) GLAUKOS CORPORATION Reports Q1 Revenue $85.6M, vs. Street Est of $79.7M
MT
Glaukos: Q1 Earnings Snapshot
AQ
Transcript : Glaukos Corporation, Q1 2024 Earnings Call, May 01, 2024
Glaukos Announces First Quarter 2024 Financial Results
BU
Glaukos Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Glaukos Announces the Release of its 2023 Sustainability Report
BU
Mizuho Securities Adjusts Price Target on Glaukos to $100 From $85, Maintains Neutral Rating
MT
Glaukos Insider Sold Shares Worth $6,008,359, According to a Recent SEC Filing
MT
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
BU
Sector Update: Health Care Stocks Rise Wednesday Afternoon
MT
Glaukos Says iDose TR Assigned Permanent J-Code From US Centers for Medicare and Medicaid Services
MT
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
BU
Glaukos Corporation Receives Permanent J-Code for iDose TR (travoprost intracameral implant)
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GKOS Stock
  4. News Glaukos Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW